bn 50739 has been researched along with ro 5-4864 in 1 studies
Studies (bn 50739) | Trials (bn 50739) | Recent Studies (post-2010) (bn 50739) | Studies (ro 5-4864) | Trials (ro 5-4864) | Recent Studies (post-2010) (ro 5-4864) |
---|---|---|---|---|---|
57 | 0 | 1 | 593 | 0 | 54 |
Protein | Taxonomy | bn 50739 (IC50) | ro 5-4864 (IC50) |
---|---|---|---|
Translocator protein | Rattus norvegicus (Norway rat) | 0.034 | |
Translocator protein | Mus musculus (house mouse) | 0.01 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barton, JM; Olson, MS; Svetlov, SI | 1 |
1 other study(ies) available for bn 50739 and ro 5-4864
Article | Year |
---|---|
The specific binding of the platelet-activating factor (PAF) receptor antagonist WEB 2086 and the benzodiazepine flunitrazepam to rat hepatocytes.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Azepines; Benzodiazepinones; Bicuculline; Cells, Cultured; Clonazepam; Convulsants; Flunitrazepam; Kinetics; Liver; Male; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles; Tritium | 1996 |